Delivery Order SPE2DB22D1106-SPE2DB25FEFL5

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,807.85 contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of April 23, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,735.00, is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,141.11 delivery order contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a firm fixed price and a period of performance through April 29, 2025. This award is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,518.18 firm fixed price contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,968.04 Firm Fixed Price Delivery Order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,646.28 firm fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
The U.S. government agency, the Medical Supply Chain division of the Defense Logistics Agency (DLA), has awarded a $5,963.52 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office division. The contract is for the supply of 4565308716 - HUMULIN R 500 UNIT/ML KWIKPEN 3ML, with a completion date of August 1, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with a ceiling value of $40,910.13 and a period of performance through May 9, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,491.69 firm fixed-price contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a medication used to treat diabetes. The award has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,495.20 delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty medication used for diabetes management. The contract has a firm fixed price and is scheduled for completion by June 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEFL5
    Delivery Order

This is a $5,033.47 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award does not have a set-aside designation, indicating open competition.

Generated 6/30/25, 10:49 AM